List of SBIR/STTR awards granted to CytoSorbents Medical Inc.
CytoSorbents Medical Inc.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. in August, 2018 for $1,979,034.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HL141928-03 | Phase II | 1,979,034 | August 20, 2018 | |||||||
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. in August, 2018 for $995,984.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HL141928-03 | Phase II | 995,984 | August 20, 2018 | |||||||
A SBIR Phase I contract was awarded to CytoSorbents Medical Inc. in September, 2022 for $281,835.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM144973-01 | Phase I | 281,835 | September 1, 2022 | |||||||
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. in September, 2020 for $1,098,589.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | W81XWH20C0087 | Phase II | 1,098,589 | September 24, 2020 | |||||||
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. in April, 2021 for $1,499,987.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | W81XWH-17-C-0142 | Phase II | 1,499,987 | April 21, 2021 | |||||||
A SBIR Phase I contract was awarded to CytoSorbents Medical Inc. in September, 2016 for $149,927.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-16-C-0080 | Phase I | 149,927 | September 8, 2016 | |||||||
A SBIR Phase I contract was awarded to CytoSorbents Medical Inc. in April, 2016 for $149,979.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-16-C-0025 | Phase I | 149,979 | April 19, 2016 | |||||||
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. in February, 2017 for $999,996.59 USD from the U.S. Department of Defense. | SBIR | W911QY-17-C-0007 | Phase II | 999,996.59 | February 1, 2017 | |||||||
A STTR Phase I contract was awarded to CytoSorbents Medical Inc. in April, 2016 for $149,979.0 USD from the U.S. Department of Defense. | STTR | W81XWH-16-C-0025 | Phase I | 149,979 | April 19, 2016 | |||||||
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. in September, 2017 for $999,871.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-17-C-0142 | Phase II | 999,871 | September 25, 2017 | |||||||
A STTR Phase II contract was awarded to CytoSorbents Medical Inc. in May, 2017 for $999,070.0 USD from the U.S. Department of Defense. | STTR | W81XWH-17-C-0053 | Phase II | 999,070 | May 15, 2017 | |||||||
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. in June, 2013 for $1,442,951.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-12-C-0038 | Phase II | 1,442,951 | June 21, 2013 | |||||||
A SBIR Phase I contract was awarded to CytoSorbents Medical Inc. in December, 2011 for $150,000.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-12-C-0038 | Phase I | 150,000 | December 8, 2011 | |||||||
A SBIR Phase I contract was awarded to CytoSorbents Medical Inc. in December, 2015 for $149,935.98 USD from the U.S. Department of Defense. | SBIR | W911QY-16-P-0048 | Phase I | 149,935.98 | December 22, 2015 | |||||||
A SBIR Phase I contract was awarded to CytoSorbents Medical Inc. for $203,351.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43HL130044 | Phase I | 203,351 | ||||||||
A SBIR Phase II contract was awarded to CytoSorbents Medical Inc. for $774,516.0 USD from the U.S. Department of Health & Human Services. | SBIR | 268201600006C-0-0-0 | Phase II | 774,516 | ||||||||
A SBIR Phase I contract was awarded to CytoSorbents Medical Inc. in November, 2022 for $74,955.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-23-P-0420 | Phase I | 74,955 | November 1, 2022 | |||||||
A SBIR Phase I contract was awarded to CytoSorbents Medical Inc. in May, 2023 for $74,918.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-23-P-0777 | Phase I | 74,918 | May 12, 2023 |
